Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD33 antibodies and use of same to treat cancer

CD33 antibodies and use of same to treat cancer

US Patent 9587019 · Granted Mar 7, 2017

Estimated economic value: $103,200,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-PD-L1 antibodies and antibody-drug conjugates2025
Anti-αVβ6 antibodies and antibody-drug conjugates2025
Camptothecin conjugates2025
Cysteine mutated antibodies for conjugation2024
Cysteine mutated antibodies for conjugation2024
Anti-AVB6 antibodies and antibody-drug conjugates2023
Glypican 3 antibodies and conjugates thereof2023
Conjugates of quaternized tubulysin compounds2023
BCMA antibodies and use of same to treat cancer and immunological disorders2023
BCMA antibodies and use of same to treat cancer and immunological disorders2023
Anti-NTB-A antibodies and related compositions and methods2022
Combination therapy using a LIV1-ADC and a chemotherapeutic2022